Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chris Boerner
Special Reports
The 10 highest-paid Big Pharma CEOs of 2024
While many familiar names appear on Fierce’s 2024 pharma CEO pay ladder, multiple executives have rubber banded across the rankings, and the top spot has gone to a dark horse contender.
Fraiser Kansteiner
,
Zoey Becker
,
Eric Sagonowsky
,
Angus Liu
,
Kevin Dunleavy
Jun 16, 2025 3:00am
Bristol Myers CEO stays bullish on Cobenfy despite trial flop
Jun 12, 2025 12:43pm
Eyeing tariffs, BMS unveils 5-year, $40B US investment
May 6, 2025 10:30am
BMS accentuates the positive after Cobenfy trial flop
Apr 24, 2025 11:31am
BMS, Merck, Amgen and more face near-term generic woes: Leerink
Nov 13, 2024 10:57am
As new drugs deliver, BMS explores further efficiency moves
Oct 31, 2024 10:27am
